©The Author(s) 2025.
World J Gastrointest Surg. Oct 27, 2025; 17(10): 109107
Published online Oct 27, 2025. doi: 10.4240/wjgs.v17.i10.109107
Published online Oct 27, 2025. doi: 10.4240/wjgs.v17.i10.109107
Table 2 Summary of differences between fibrolamellar and convention hepatocellular carcinoma
| Feature | FLHCC | Conventional HCC |
| Typical age group | Adolescents/young adults | Older adults with liver disease |
| Underlying liver disease | Absent | Often present |
| AFP elevation | Rare | Common |
| Histology | Large eosinophilic cells, fibrous lamellae | Variable, often trabecular |
| Genetic alterations | DNAJB1-PRKACA fusion | TP53, TERT, CTNNB1 mutations |
| Common metastasis sites | Lymph nodes, lungs, peritoneum | Lungs, bones |
- Citation: da Fonseca LG, Araujo RLC. Fibrolamellar hepatocellular carcinoma: Advances, challenges and opportunities in a rare malignancy. World J Gastrointest Surg 2025; 17(10): 109107
- URL: https://www.wjgnet.com/1948-9366/full/v17/i10/109107.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i10.109107